Patients getting faster access to cancer drugs as NICE approves three quarters of the Cancer Drugs Fund

Liver cancer drug, sorafenib has been approved for routine NHS use, marking three quarters of the way through the Cancer Drugs Fund (CDF) without a negative decision.

Read article

Osteoporotic hip fracture - 200 x 200

Thousands more people could be offered drugs to prevent bone fractures because of osteoporosis

NICE has published new guidance on the use of drugs called bisphosphonates for preventing bone fractures in people at increased risk.

Read article

Pacnreas surgery_200x200

Pancreatic cancer patients to have routine access to life extending drug after new deal, says NICE

NICE has recommended nab-paclitaxel for routine NHS use after the company agreed a confidential price discount and provided more evidence on its effectiveness.

Read article

data and calculator -- 200X200

Roche invited to submit a CDF proposal for urothelial cancer drug

NICE has asked Roche to submit a Cancer Drugs Fund (CDF) proposal for an immunotherapy treatment called atezolizumab.

Read article

Latest news headlines